BofA starts Biohaven at purchase, cites “fast-follower” approach (NYSE:BHVN)08/27/2024 peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase score, citing its drug improvement packages for temper and autoimmune problems. The funding financial institution mentioned…
